Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

As we age, our cells don’t just wear down—they reorganize. Researchers found that cells actively remodel a key structure called the endoplasmic reticulum, reducing protein-producing regions while ...

Cell and gene therapies (CGTs) are built on living systems. From early research through commercial distribution, the integrity of those systems depends on the ability to preserve cells without ...

Perfection Global is selling equipment from a recently commissioned foamed and cellular glass aggregate production operation, the former GlassWRX in Beaufort, South Carolina, presenting recyclers with ...

The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

A study on worms led by researchers from Vanderbilt University School of Medicine in the US has uncovered a previously unknown adaptation to aging that actively remodels one of the largest and most ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new Johnson & Johnson plant ...

Oracle is offering new capabilities in Oracle Fusion Cloud Supply Chain & Manufacturing (SCM) to help organizations manage the unique requirements of process manufacturing. According to Oracle, the ...

Jupiter International has commissioned a 1 GW mono PERC solar cell manufacturing facility at its Baddi site in Himachal Pradesh, increasing its total installed capacity to nearly 2 GW from 959 MW. The ...

GeminiBio provides serum, customized media, buffers, and process liquids to biopharma and advanced therapy companies focused on the research and production of mRNA, AAV, monoclonal antibody, and cell ...

(RTTNews) - Tesla (TSLA) is moving quickly to turn Elon Musk's ambitious solar goals into reality, evaluating several U.S. locations to begin large-scale solar cell manufacturing, according to people ...